| P50 | author | Ben Babourina-Brooks | Q51504366 |
| | Andrew C Peet | Q56074825 |
| | Martin Wilson | Q40132433 |
| | Nigel P. Davies | Q50646792 |
| P2093 | author name string | Sarah Kohe | |
| | Lesley MacPherson | |
| | Simrandip K Gill | |
| P2860 | cites work | Magnetic resonance spectroscopy - Revisiting the biochemical and molecular milieu of brain tumors | Q26751140 |
| | Serine, glycine and one-carbon units: cancer metabolism in full circle | Q26828610 |
| | Using magnetic resonance imaging and spectroscopy in cancer diagnostics and monitoring: preclinical and clinical approaches | Q26865120 |
| | Nonhistological diagnosis of human cerebral tumors by 1H magnetic resonance spectroscopy and amino acid analysis. | Q52072183 |
| | Potential role of in vitro 1H magnetic resonance spectroscopy in the definition of malignancy grading of human neuroepithelial brain tumours. | Q55478978 |
| | Differentiation of glioblastoma multiforme from astrocytomas by in vitro 1H MRS analysis of human brain tumors. | Q55479693 |
| | Proton magnetic resonance spectroscopy of brain tumors: an in vitro study. | Q55481734 |
| | High tumor glycine concentration is an adverse prognostic factor in locally advanced rectal cancer | Q57095431 |
| | The value of magnetic resonance spectroscopy in tumour imaging | Q57919348 |
| | Glycine decarboxylase cleaves a "malignant" metabolic path to promote tumor initiation | Q83461124 |
| | 1H- and (31)P-MR spectroscopy of primary and recurrent human brain tumors in vitro: malignancy-characteristic profiles of water soluble and lipophilic spectral components | Q30657505 |
| | Could assessment of glioma methylene lipid resonance by in vivo (1)H-MRS be of clinical value? | Q30811538 |
| | A constrained least-squares approach to the automated quantitation of in vivo ¹H magnetic resonance spectroscopy data | Q33705626 |
| | Differential expression of enzymes associated with serine/glycine metabolism in different breast cancer subtypes. | Q33825671 |
| | Measurement of glycine in the human brain in vivo by 1H-MRS at 3 T: application in brain tumors | Q33843492 |
| | Noninvasive detection of glutamate predicts survival in pediatric medulloblastoma | Q34134686 |
| | Feasibility of MR metabolomics for immediate analysis of resection margins during breast cancer surgery | Q34684585 |
| | Molecular subgroups of medulloblastoma identification using noninvasive magnetic resonance spectroscopy. | Q36367397 |
| | Metabolite profiling identifies a key role for glycine in rapid cancer cell proliferation | Q36477750 |
| | Integration of 2-hydroxyglutarate-proton magnetic resonance spectroscopy into clinical practice for disease monitoring in isocitrate dehydrogenase-mutant glioma | Q36493858 |
| | Magnetic resonance spectroscopy metabolite profiles predict survival in paediatric brain tumours | Q36575246 |
| | REporting recommendations for tumour MARKer prognostic studies (REMARK) | Q36615178 |
| | Treatment of pediatric brain tumors | Q36953476 |
| | Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype. | Q36982043 |
| | Metabolism of diffuse intrinsic brainstem gliomas in children | Q37010991 |
| | High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors | Q37024727 |
| | Diagnosing relapse in children's brain tumors using metabolite profiles | Q37409750 |
| | Glycine metabolism in animals and humans: implications for nutrition and health | Q38101481 |
| | Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis. | Q39416388 |
| | Phospholipid metabolites in 1H-decoupled 31P MRS in vivo in human cancer: implications for experimental models and clinical studies. | Q41023979 |
| | Non-invasive detection of glycine as a biomarker of malignancy in childhood brain tumours using in-vivo 1H MRS at 1.5 tesla confirmed by ex-vivo high-resolution magic-angle spinning NMR. | Q43268774 |
| | Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localised proton spectroscopy of brain | Q43632743 |
| | 1H MR spectroscopic imaging with short and long echo time to discriminate glycine in glial tumours. | Q43790888 |
| | MRS of pilocytic astrocytoma: The peak at 2 ppm may not be NAA. | Q45964611 |
| | Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. | Q46493842 |
| | Metabolic differences between primary and recurrent human brain tumors: a 1H NMR spectroscopic investigation | Q46549871 |
| | An investigation of human brain tumour lipids by high-resolution magic angle spinning 1H MRS and histological analysis | Q46815114 |
| | Predicting survival of children with CNS tumors using proton magnetic resonance spectroscopic imaging biomarkers | Q48288273 |
| | Localized proton NMR spectroscopy of brain tumors using short-echo time STEAM sequences | Q48626844 |
| P433 | issue | 27 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | biomarker | Q864574 |
| | non-invasive imaging | Q28946191 |
| P304 | page(s) | 18858-18868 | |
| P577 | publication date | 2018-04-10 | |
| P1433 | published in | Oncotarget | Q1573155 |
| P1476 | title | Glycine: a non-invasive imaging biomarker to aid magnetic resonance spectroscopy in the prediction of survival in paediatric brain tumours. | |
| P478 | volume | 9 | |